
Pharmacogenomic Tests ground-breaking Tests to revolutionise medicine
As early as next year pharmacogenomic tests could be made available on the NHS.
As early as next year pharmacogenomic tests could be made available on the NHS.
Mobocertinib has now been fast-tracked and will be made available to NHS England eligible lung cancer patients within weeks.
NHS Covid Pass, as of Monday the 19th of July you may be requested to demonstrate your COVID-19 Status at places in England that use the service as a condition of entry to a venue or event.
The number of digital consultations has exploded during the pandemic and for some it has been fantastic, but for other is in not a suitable mode of to name a few; elderly who are not silver surfers and autistic children.
We have heard a few times before that the Healthcare Regulators should…